描述 |
Beclometasone二丙酸盐是糖皮质素激动剂,为beclometasone游离形式的原药。 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
相关类别 |
|
||||||||||||
溶解度 |
体外:
DMSO:≥100mg / mL(191.92 mM) * “≥”表示可溶,但饱和度未知。
|
||||||||||||
储备液 |
|
||||||||||||
存储 |
|
||||||||||||
运输 |
室温;可能会有所不同 |
||||||||||||
SMILES |
C[C@@]12[C@](C[C@H](C)[C@]2(OC(CC)=O)C(COC(CC)=O)=O)([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C1)=O |
||||||||||||
参考文献 |
|
||||||||||||
相关活性 小分子 |
氢化可的松 | 米非司酮 | 皮质酮 | 泼尼松 | 原人参三醇 | 氟替卡松丙酸酯 | 曲安西龙 | 可的松 | AL 082D06 | 糖皮质激素受体激动剂 | Mapracorat | 环索奈德 | 丙酸氯倍他索 | Cort108297 | 氟尼缩松 |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 630.5±55.0 °C at 760 mmHg |
熔点 | 210?C |
分子式 | C28H37ClO7 |
分子量 | 521.042 |
闪点 | 335.1±31.5 °C |
精确质量 | 520.222778 |
PSA | 106.97000 |
LogP | 4.59 |
外观性状 | 白色结晶粉末 |
蒸汽压 | 0.0±4.2 mmHg at 25°C |
折射率 | 1.564 |
储存条件 |
2-8℃ 避光,阴凉干燥处,密封保存 v |
稳定性 |
常温常压下稳定,类白色或微黄色结晶性粉 |
分子结构 |
1、 摩尔折射率:133.38 2、 摩尔体积(m3/mol):410.2 3、 等张比容(90.2K):1099.5 4、 表面张力(dyne/cm):51.5 5、 极化率(10 -24cm 3):52.87 |
计算化学 |
1、 疏水参数计算参考值(XlogP):3.1 2、 氢键供体数量:2 3、 氢键受体数量:6 4、 可旋转化学键数量:6 5、 互变异构体数量:8 6、 拓扑分子极性表面积(TPSA):83.6 7、 重原子数量:26 8、 表面电荷:0 9、 复杂度:516 10、 同位素原子数量:0 11、 确定原子立构中心数量:0 12、 不确定原子立构中心数量:1 13、 确定化学键立构中心数量:0 14、 不确定化学键立构中心数量:0 15、 共价键单元数量:1 |
更多 |
1. 性状:未确定 2. 密度(g/mL,25/4℃):未确定 3. 相对蒸汽密度(g/mL,空气=1):未确定 4. 熔点(?C):未确定 5. 沸点(?C,常压):未确定 6. 沸点(?C,5.2kPa):未确定 7. 折射率:未确定 8. 闪点(?C):未确定 9. 比旋光度(?):未确定 10. 自燃点或引燃温度(?C):未确定 11. 蒸气压(kPa,25?C):未确定 12. 饱和蒸气压(kPa,60?C):未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(?C):未确定 15. 临界压力(KPa):未确定 16. 油水(辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:未确定 |
|
丙酸倍氯米松毒性英文版
|
符号 |
GHS08 |
---|---|
信号词 |
Danger |
危害声明 |
H360 |
警示性声明 |
P201-P308 + P313 |
个人防护装备 |
Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
危害码 (欧洲) |
T:Toxic |
风险声明 (欧洲) |
R60;R61 |
安全声明 (欧洲) |
S53-S36/37/39-S45 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | TU3805000 |
海关编码 | 2937290090 |
海关编码 | 2937290090 |
---|
The use of hydrazine-based derivatization reagents for improved sensitivity and detection of carbonyl containing compounds using MALDI-MSI. Anal. Bioanal. Chem 407(8) , 2085-94, (2015)
Hydrazine-based derivatization reagents have been used to detect the presence of the carbonyl containing glucocorticoid fluticasone proprionate in rat lung tissue by MALDI-MSI. Such reagents also act …
|
|
[Beclomethasone dipropionate, budesonide and flunisolide in the treatment of bronchial asthma (a review of the literature and the authors' own research)]. Ter. Arkh. 67(3) , 34-8, (1995)
Inhalation corticosteroids (beclometasone dipropionate, budesonide, flunisolide) proved effective against bronchial asthma (BA) and safe as they induce no severe systemic side effects. Of these three …
|
|
Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology. Int. J. Pharm. 444(1-2) , 193-9, (2013)
The aerosol properties of niosomes were studied using Aeroneb Pro and Omron MicroAir vibrating-mesh nebulizers and Pari LC Sprint air-jet nebulizer. Proniosomes were prepared by coating sucrose partic…
|
|
9-Chloro-16-β-methyl-11-β,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-Dipropionate |
Viarex |
Beconasol |
Becloval |
(11b,16b)-9-Chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-pregna-1,4-diene-3,20-dione |
(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-[(propanoyloxy)acetyl]-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propanoate |
Becodisks |
pregna-1,4-diene-3,20-dione, 9-chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11b,16b)- |
Anceron |
Vancenase AQ |
propanoate de (8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-triméthyl-3-oxo-17-[(propanoyloxy)acétyl]-6,7,8,9,10,11,12,13,14,15,16,17-dodécahydro-3H-cyclopenta[a]phénanthrén-17-yle |
(11b,16b)-9-chloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate |
Pregna-1,4-diene-3,20-dione, 9-chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11β,16β)- |
(11β,16β)-9-Chloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate |
EINECS 226-886-0 |
Beclomethasone dipropionate (USP) |
Beclomethasone dipropionate |
Andion |
MFCD00135613 |
(8S,9R,10S,11S,13S,14S,16S,17R)-9-Chlor-11-hydroxy-10,13,16-trimethyl-3-oxo-17-[(propanoyloxy)acetyl]-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-ylpropanoat |
9-Chloro-11b-hydroxy-16b-methylpregna-1,4-diene-3,20-dione 17,21-Dipropionate |
Beclometasone dipropionate |